Titel

Merkliste
1 Ergebnisse

image1_Phase I Trial to Evaluate the Tolerance, Pharmacokin..:

Jingrui Liu (1694983) ; Hong Zhang (25820) ; Xiaoxue Zhu (562629)...
https://figshare.com/articles/figure/image1_Phase_I_Trial_to_Evaluate_the_Tolerance_Pharmacokinetics_and_Efficacy_of_the_Broad-Spectrum_ErbB_Family_Inhibitor_Larotinib_Mesylate_in_Patients_With_Advanced_Solid_Tumors_tif/14051792. , 2021

Link: https://doi.org/10.3389/fphar.2021.636324.s001

RT Journal
T1 <Title>image1_Phase I Trial to Evaluate the Tolerance, Pharmacokinetics and Efficacy of the Broad-Spectrum ErbB Family Inhibitor Larotinib Mesylate in Patients With Advanced Solid Tumors.tif</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_14051792&Exemplar=1&LAN=DE
				
A1 Jingrui Liu (1694983)
A1 Hong Zhang (25820)
A1 Xiaoxue Zhu (562629)
A1 Hong Chen (108084)
A1 Xiaojiao Li (193668)
A1 Yanhua Ding (132997)
YR 2021
K1 Pharmacology
K1 Basic Pharmacology
K1 Clinical Pharmacology and Therapeutics
K1 Clinical Pharmacy and Pharmacy Practice
K1 Pharmaceutical Sciences
K1 Pharmacogenomics
K1 Toxicology (incl. Clinical Toxicology)
K1 Pharmacology and Pharmaceutical Sciences not elsewhere classified
K1 larotinib
K1 phase I
K1 dose escalation
K1 ErbB family blocker
K1 pharmacokinetics
JF https://figshare.com/articles/figure/image1_Phase_I_Trial_to_Evaluate_the_Tolerance_Pharmacokinetics_and_Efficacy_of_the_Broad-Spectrum_ErbB_Family_Inhibitor_Larotinib_Mesylate_in_Patients_With_Advanced_Solid_Tumors_tif/14051792
LK http://dx.doi.org/https://doi.org/10.3389/fphar.2021.636324.s001
DO https://doi.org/10.3389/fphar.2021.636324.s001
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)